AMN

SEC source: 0001209191-21-028093 · doc4.xml · derivative · entry 3

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,139

Underlying: Common Stock · 2,139 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028093 · doc4.xml · derivative · entry 2

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,826 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 22, 2020 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2021. Accordingly, the number of RSUs identified in this row vested on April 21, 2021, which was the date of the Company's Annual Meeting of Shareholders in 2021.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028093 · doc4.xml · nonDerivative · entry 1

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,916

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 18

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,984 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F21 · derivative.exercise_date: The RSUs were granted on April 8, 2008 and vested in three tranches on the first, second and third anniversaries of the grant date.

F12 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 17

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,563 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F20 · derivative.exercise_date: The RSUs were granted on April 9, 2009 and vested in three tranches on the first, second and third anniversaries of the grant date.

F12 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 16

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,563 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F19 · derivative.exercise_date: The RSUs were granted on April 13, 2010 and vested in three tranches on the first, second and third anniversaries of the grant date.

F12 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 15

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,490 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F18 · derivative.exercise_date: The RSUs were granted on April 23, 2014 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2015 Annual Meeting of Shareholders.

F12 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 14

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,532 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F17 · derivative.exercise_date: The RSUs were granted on April 22, 2015 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2016 Annual Meeting of Shareholders.

F12 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 13

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,793 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F16 · derivative.exercise_date: The RSUs were granted on April 20, 2016 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2017 Annual Meeting of Shareholders.

F12 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 12

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,365 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F15 · derivative.exercise_date: The RSUs were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2018 Annual Meeting of Shareholders.

F12 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 11

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F13 · derivative.exercise_date: The RSUs were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2019 Annual Meeting of Shareholders.

F12 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 10

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,826 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F11 · derivative.exercise_date: The RSUs were granted on April 24, 2013 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2014 Annual Meeting of Shareholders.

F12 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 9

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,269

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on December 23, 2008. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 8

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,285

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 9, 2009. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 7

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,722

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 13, 2010. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 6

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,159

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 23, 2014. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 5

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,669

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 22, 2015. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 4

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 20, 2016. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 3

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,344

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 18, 2017. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 2

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,979

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 18, 2018. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 1

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,826

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-21-028089 · doc4.xml · derivative · entry 3

Jones Daphne E · CIK 0001475924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,139

Underlying: Common Stock · 2,139 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022. At the reporting person's irrevocable election, the number of Restricted Stock Units identified in this row will settle on the date of the director's termination of service with the Company.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028089 · doc4.xml · derivative · entry 2

Jones Daphne E · CIK 0001475924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,826 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 22, 2020 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2021. Accordingly, the number of RSUs identified in this row vested on April 21, 2021, which was the date of the Company's Annual Meeting of Shareholders in 2021.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028089 · doc4.xml · nonDerivative · entry 1

Jones Daphne E · CIK 0001475924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,341

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-21-028085 · doc4.xml · derivative · entry 3

Fontenot Teri G. · CIK 0001661066 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,139

Underlying: Common Stock · 2,139 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022. At the reporting person's irrevocable election, the number of Restricted Stock Units identified in this row will settle on the date of the director's termination of service with the Company.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028085 · doc4.xml · derivative · entry 2

Fontenot Teri G. · CIK 0001661066 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,826 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 22, 2020 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2021. Accordingly, the number of RSUs identified in this row vested on April 21, 2021, which was the date of the Company's Annual Meeting of Shareholders in 2021.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028085 · doc4.xml · nonDerivative · entry 1

Fontenot Teri G. · CIK 0001661066 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,826

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-21-028087 · doc4.xml · derivative · entry 3

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,139

Underlying: Common Stock · 2,139 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028087 · doc4.xml · derivative · entry 2

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,826 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 22, 2020 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2021. Accordingly, the number of RSUs identified in this row vested on April 21, 2021, which was the date of the Company's Annual Meeting of Shareholders in 2021.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028087 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,322

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-21-028083 · doc4.xml · derivative · entry 3

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,139

Underlying: Common Stock · 2,139 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028083 · doc4.xml · derivative · entry 2

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,826 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 22, 2020 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2021. Accordingly, the number of RSUs identified in this row vested on April 21, 2021, which was the date of the Company's Annual Meeting of Shareholders in 2021.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028083 · doc4.xml · nonDerivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,776

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-21-021172 · doc4.xml · nonDerivative · entry 1

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,090

SEC source: 0001209191-21-020276 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,752

SEC source: 0001209191-21-014001 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,997

F1 · kind: The sale of 2,726 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $73.105396 per share. These shares were sold in multiple transactions at prices ranging from $72.22 to $73.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-21-013896 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,752

F1 · kind: The sale of 1,400 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $74.6741 per share. These shares were sold in multiple transactions at prices ranging from $74.63 to $74.745, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-23-021663 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,402

F1 · date: Filed late due to administrative error.

F4 · kind: Number of shares withheld for tax purposes.

F3 · balance_after: Due to the late filing, the amount of securities beneficially owned by the Reporting Person following the reported transactions in subsequently filed Form 4s have been understated.

SEC source: 0001209191-23-021663 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,143

F1 · date: Filed late due to administrative error.

F2 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2018. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2020 over a three-year period beginning on January 1, 2018 and ended December 31, 2020. As a result, 70% of the target amount of PRSUs for this award were deemed earned and vested.

F3 · balance_after: Due to the late filing, the amount of securities beneficially owned by the Reporting Person following the reported transactions in subsequently filed Form 4s have been understated.

SEC source: 0001209191-21-002678 · doc4.xml · nonDerivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,152

F5 · kind: The sale of 798 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · price: The price reported in this row represents a weighted average price of $70.4486 per share. These shares were sold in multiple transactions at prices ranging from $70.31 to $70.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-002180 · doc4.xml · derivative · entry 4

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,369

Underlying: Common Stock · 1,166 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The RSUs identified in this row were granted on January 6, 2020 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-002180 · doc4.xml · nonDerivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,382

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-002180 · doc4.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,831

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-002471 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,723

F3 · kind: The sale of 14,882 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported in this row represents a weighted average price of $71.276916 per share. These shares were sold in multiple transactions at prices ranging from $69.68 to $72.085, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F5 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-21-002683 · doc4.xml · derivative · entry 3

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,133

Underlying: Common Stock · 2,035 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The RSUs identified in this row were granted on January 4, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-002683 · doc4.xml · nonDerivative · entry 2

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,337

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-002683 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,041

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-002678 · doc4.xml · derivative · entry 5

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,480

Underlying: Common Stock · 1,221 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F8 · derivative.exercise_date: The RSUs identified in this row were granted on January 6, 2020 and vest in three tranches on each of the first, second and third anniversaries of the grant date.

F9 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-002678 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,950

F3 · kind: The sale of 788 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported in this row represents a weighted average price of $71.1705 per share. These shares were sold in multiple transactions at prices ranging from $71.005 to $71.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-002678 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,822

F2 · kind: Number of shares withheld for tax purposes.